Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will present a review of products in development and a financial...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and...

aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced the...

Skreens is demonstrating its latest Consumer Integrated Display Platform at CES 2016, enabled by Xilinx's All Programmable SoC technology. The Skreens Plus series of devices enable gamers,...

Caris Life Sciences®,a leading biotechnology company focused on fulfilling the promise of precision medicine, announces today that it will present four poster presentations at the 2016...